New diabetes drug aims to improve daily glucose control
NCT ID NCT07215312
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study tests a new medicine called LY3938577 against a standard insulin (degludec) in 100 adults with type 2 diabetes who already use basal insulin. The goal is to see if the new drug helps keep blood sugar in a healthy range more safely and effectively over about 26 weeks. Participants must have an HbA1c between 7.5% and 10.5% and a BMI under 35.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMR Clinical
Norman, Oklahoma, 73069, United States
-
Accellacare - Wilmington
Wilmington, North Carolina, 28401, United States
-
CIPREC
Buenos Aires, C1119ACN, Argentina
-
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, C1425AGC, Argentina
-
Chrysalis Clinical Research
St. George, Utah, 84790, United States
-
Cicemo Srl
Buenos Aires, 1424, Argentina
-
Clinical Research of Central Florida
Lakeland, Florida, 33805, United States
-
Consano Clinical Research, LLC
Shavano Park, Texas, 78231, United States
-
Encompass Clinical Research
Spring Valley, California, 91978, United States
-
Encore Medical Research
Hollywood, Florida, 33024, United States
-
Encore Medical Research - Weston
Weston, Florida, 33331, United States
-
Holston Medical Group
Bristol, Tennessee, 37620, United States
-
Instituto Centenario
CABA, 1204, Argentina
-
Instituto Médico Catamarca IMEC
Rosario, 2000, Argentina
-
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, 50266, United States
-
Juno Research
Houston, Texas, 77040, United States
-
Mautalen Salud e Investigación
Buenos Aires, C1128AAF, Argentina
-
Southern Endocrinology Associates
Mesquite, Texas, 75149, United States
-
Tampa Bay Medical Research
Clearwater, Florida, 33761, United States
-
Texas Diabetes & Endocrinology, P.A.
Austin, Texas, 78749, United States
-
Texas Valley Clinical Research
Weslaco, Texas, 78596, United States
-
Tribe Clinical Research, LLC
Greenville, South Carolina, 29607, United States
-
Tucson Clinical Research Institute
Tucson, Arizona, 85712, United States
-
University Clinical Investigators, Inc.
Tustin, California, 92780, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a puff of insulin replace a needle for diabetes?
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Can a puff of insulin replace a daily shot for diabetes?
- Could a Dairy-Rich diet tame type 2 diabetes?
- Can a traditional herbal remedy tame type 2 diabetes?